Literature DB >> 12138997

Nemaline and myotubular myopathies.

Carina Wallgren-Pettersson1.   

Abstract

Nemaline myopathy is caused by mutations in one of at least six different genes. The clinical picture also varies widely, in terms of the grade and the distribution of muscle weakness. In familial cases, autosomal-recessive inheritance is more common than autosomal-dominant inheritance, and in some patients the disorder is caused by new dominant mutations. Because of the genetic heterogeneity and the large size of one of the genes commonly involved, that is, nebulin, no routine molecular genetic testing is yet available. Thus, the diagnosis often still rests on clinical and histologic criteria. Prenatal diagnosis can only reliably be performed in families where the causative mutation(s) have been identified. No clear-cut prognostic indicators are known, and treatment decisions can only be taken in casu. In the long-term management of patients with nemaline myopathy, respiratory capacity requires regular monitoring for early detection of insidious hypoventilation.

Entities:  

Mesh:

Year:  2002        PMID: 12138997     DOI: 10.1053/spen.2002.33804

Source DB:  PubMed          Journal:  Semin Pediatr Neurol        ISSN: 1071-9091            Impact factor:   1.636


  4 in total

1.  Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin.

Authors:  Yufeng Yang; Stephan Gehrke; Yuzuru Imai; Zhinong Huang; Yingshi Ouyang; Ji-Wu Wang; Lichuan Yang; M Flint Beal; Hannes Vogel; Bingwei Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-03       Impact factor: 11.205

Review 2.  Muscle giants: molecular scaffolds in sarcomerogenesis.

Authors:  Aikaterini Kontrogianni-Konstantopoulos; Maegen A Ackermann; Amber L Bowman; Solomon V Yap; Robert J Bloch
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

3.  Consensus statement on standard of care for congenital myopathies.

Authors:  Ching H Wang; James J Dowling; Kathryn North; Mary K Schroth; Thomas Sejersen; Frederic Shapiro; Jonathan Bellini; Hali Weiss; Marc Guillet; Kimberly Amburgey; Susan Apkon; Enrico Bertini; Carsten Bonnemann; Nigel Clarke; Anne M Connolly; Brigitte Estournet-Mathiaud; Dominic Fitzgerald; Julaine M Florence; Richard Gee; Juliana Gurgel-Giannetti; Allan M Glanzman; Brittany Hofmeister; Heinz Jungbluth; Anastassios C Koumbourlis; Nigel G Laing; Marion Main; Leslie A Morrison; Craig Munns; Kristy Rose; Pamela M Schuler; Caroline Sewry; Kari Storhaug; Mariz Vainzof; Nanci Yuan
Journal:  J Child Neurol       Date:  2012-03       Impact factor: 1.987

4.  Identification of KLHL41 Mutations Implicates BTB-Kelch-Mediated Ubiquitination as an Alternate Pathway to Myofibrillar Disruption in Nemaline Myopathy.

Authors:  Vandana A Gupta; Gianina Ravenscroft; Ranad Shaheen; Emily J Todd; Lindsay C Swanson; Masaaki Shiina; Kazuhiro Ogata; Cynthia Hsu; Nigel F Clarke; Basil T Darras; Michelle A Farrar; Amal Hashem; Nicholas D Manton; Francesco Muntoni; Kathryn N North; Sarah A Sandaradura; Ichizo Nishino; Yukiko K Hayashi; Caroline A Sewry; Elizabeth M Thompson; Kyle S Yau; Catherine A Brownstein; Timothy W Yu; Richard J N Allcock; Mark R Davis; Carina Wallgren-Pettersson; Naomichi Matsumoto; Fowzan S Alkuraya; Nigel G Laing; Alan H Beggs
Journal:  Am J Hum Genet       Date:  2013-11-21       Impact factor: 11.025

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.